Matinas BioPharma Holdings (MTNB) Cash from Investing Activities Growth (1y) (2014 - 2025)
Matinas BioPharma Holdings (MTNB) Cash from Investing Activities Growth (1y) (2014 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -114.28% |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 826.39% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -674.01% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Matinas BioPharma Holdings | 4.60 Mn | 2.15 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -97.00% |
| Dec 31, 2024 | -83.11% |
| Sep 30, 2024 | 789.85% |
| Jun 30, 2024 | -147.40% |
| Mar 31, 2024 | -33.33% |
| Dec 31, 2023 | 7,147.62% |
| Sep 30, 2023 | -81.15% |
| Jun 30, 2023 | 263.45% |
| Mar 31, 2023 | 1.32% |
| Dec 31, 2022 | -174.14% |
| Sep 30, 2022 | 2,269.23% |
| Jun 30, 2022 | -149.54% |
| Mar 31, 2022 | -66.42% |
| Dec 31, 2021 | -99.38% |
| Sep 30, 2021 | 108.73% |
| Jun 30, 2021 | -4.23% |
| Mar 31, 2021 | 116.04% |
| Dec 31, 2020 | 262.15% |
| Sep 30, 2020 | -3,686.07% |
| Jun 30, 2020 | 2,613.61% |